See All Slides - tctmd.com

Slides

Presentation TCT 2012

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Presenter: Alexander Kharlamov

October 23, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

TCT-90. Predictive Factors and Long-Term Clinical Consequences of Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve Implantation with a...

Presenter: Maria Urena

October 23, 2012

Presentation TCT 2012

Background Medical and Device Therapies for Patients with VADs

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

COAPT

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

ELM Presentation(8)

Presenter: Paul Sorajja

October 23, 2012

Presentation TCT 2012

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

The New Anticoagulants: A Meaningful Step Forward?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

ROADMAP

Presenter: John O'Connell

October 23, 2012

Advertisement

Slides

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Viability Testing, Clinical Decision Making(2)

TCT-90. Predictive Factors and Long-Term Clinical Consequences of Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve Implantation with a...

Background Medical and Device Therapies for Patients with VADs

COAPT

ELM Presentation(8)

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

The New Anticoagulants: A Meaningful Step Forward?

ROADMAP

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content